DANA QUINN: Open Payments
NPI 1982117438 · MARLTON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,601 in 61 payments from 22 companies in 2025. Trend: 2023 $1,034 · 2024 $715 · 2025 $6,601
Speaker / faculty: $5,444Food & beverage: $1,157
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 28 | $5,859 |
| W. L. Gore & Associates, Inc. | 1 | $122 |
| UCB, Inc. | 5 | $91 |
| Lilly USA, LLC | 3 | $58 |
| Boston Scientific Corporation | 2 | $56 |
| Genentech USA, Inc. | 2 | $47 |
| Biogen, Inc. | 2 | $46 |
| SK Life Science, Inc. | 2 | $42 |
| Axsome Therapeutics, Inc. | 2 | $35 |
| Novartis Pharmaceuticals Corporation | 2 | $29 |
Products named: UBRELVY, QULIPTA, GORE CARDIOFORM Septal Occluder, BOTOX, AMYVID, General - DBS, Briviact, Ocrevus Zunovo.
Industry payments across NJ — which companies pay providers there.
